A securities class action has been filed in the USDC – N.D.CA. against Synopsys, Inc. (SNPS) (“Synopsys” or the “Company”), on behalf of all persons and entities that: (a) all persons and entities that purchased or otherwise acquired Synopsys securities between December 4. 2024, and September 9, 2025; and (b) all persons who purchased or […]
A securities class action has been filed in the USDC — E.D.PA. against Avantor, Inc. (AVTR) (“Avantor” or the “Company”) on behalf of all persons and entities that purchased or otherwise acquired Avantor common stock between March 5, 2024, and October 28, 2025, both dates inclusive (the “Class Period”). Avantor is a laboratory supply […]
A securities class action has been filed in the USDC –N.J. against Wildermuth Fund (WEFCX) (the “Fund”), on behalf of all persons and entities that purchased Class A (WESFX), Class C (WEFCX), and/or Class I (WEIFX) shares in the Wildermuth Fund (a/k/a the Wildermuth Endowment Fund and Wildermuth Endowment Strategy Fund, or the “Fund”) between […]
A securities class action has been filed in the USDC – S.D.N.Y. against Dexcom, Inc. (DXCM) (“DexCom” or the “Company”), on behalf of all persons and entities that purchased or otherwise acquired DexCom common stock between January 8, 2024, and September 17, 2025, both dates inclusive (the “Class Period”). Dexcom develops, manufactures, and markets […]
A securities class action has been filed in the USDC – N.D.IL. against James Hardie Industries plc. (JHX) (“James Hardie” or the “Company”), on behalf of all persons and entities that purchased or otherwise acquired James Hardie common stock (previously American Depositary Shares until their conversion to common stock on July 1, 2025) between May […]